Literature DB >> 21120195

Is RARS-T a new disease entity or a subtype of RARS or ET?

Soo-Mee Bang.   

Abstract

Entities:  

Year:  2010        PMID： 21120195      PMCID： PMC2983031          DOI： 10.5045/kjh.2010.45.2.139

Source DB:  PubMed          Journal:  Korean J Hematol        ISSN： 1738-7949


× No keyword cloud information.
  5 in total

1.  MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.

Authors:  Animesh D Pardanani; Ross L Levine; Terra Lasho; Yana Pikman; Ruben A Mesa; Martha Wadleigh; David P Steensma; Michelle A Elliott; Alexandra P Wolanskyj; William J Hogan; Rebecca F McClure; Mark R Litzow; D Gary Gilliland; Ayalew Tefferi
Journal:  Blood       Date:  2006-07-25       Impact factor: 22.113

2.  JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia.

Authors:  Dong Wook Jekarl; Sang Bong Han; Myungshin Kim; Jihyang Lim; Eun-Jee Oh; Yonggoo Kim; Hee-Je Kim; Woo-Sung Min; Kyungja Han
Journal:  Korean J Hematol       Date:  2010-03-31

3.  JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

Authors:  Annette H Schmitt-Graeff; Soon-Siong Teo; Manfred Olschewski; Franz Schaub; Sabine Haxelmans; Andreas Kirn; Petra Reinecke; Ulrich Germing; Radek C Skoda
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

4.  Prevalence and distribution of ringed sideroblasts in primary myelodysplastic syndromes.

Authors:  S K Juneja; M Imbert; F Sigaux; H Jouault; C Sultan
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

Review 5.  Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?

Authors:  Douglas Wardrop; David P Steensma
Journal:  Br J Haematol       Date:  2008-12-11       Impact factor: 6.998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.